Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells
<p>Abstract</p> <p>Background</p> <p>A major problem with the use of current chemotherapy regimens for several cancers, including breast cancer, is development of intrinsic or acquired drug resistance, which results in disease recurrence and metastasis. However, the mec...
Main Authors: | Choi Changsun, Kim Sunshin, Jeong Kyung-Chae, Song Ki-Hoon, Kang Ju-Hee, Lee Chang, Oh Seung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-08-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/334 |
Similar Items
-
Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy
by: Mi Hwa Heo, et al.
Published: (2019-09-01) -
Role of COX-2 in the regulation of the metastatic potential of human breast tumor cells
by: M. A. Taipov, et al.
Published: (2014-07-01) -
Combination chemotherapy in the treatment of breast cancer patients with metastatic brain involvement and a poor prognosis
by: D. R. Naskhletashvili, et al.
Published: (2014-07-01) -
Utilization and Cost-Effectiveness Analysis of Chemotherapy for Patients with Metastatic Breast Cancer
by: Chin-Ju Tsai, et al.
Published: (2018) -
Principles of Monitoring Metastatic Disease and Chemotherapy Regimens for Recurrent or Metastatic Breast Cancer
by: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 1.213)
Published: (2013-06-01)